Alzchem Group AG's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 49.01.
Alzchem Group AG's Days Inventory for the
three
months ended in Mar. 2026 was 222.12.
Alzchem Group AG's Days Payable for the
three
months ended in Mar. 2026 was 96.32.
Therefore, Alzchem Group AG's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 174.81.
Alzchem Group AG (XTER:ACT) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Alzchem Group AG Cash Conversion Cycle Related Terms
Alzchem Group AG Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Alzchem Group AG's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:ACT vs LIN, SHW, ECL: Cash Conversion Cycle Comparison
For the Specialty Chemicals subindustry, Alzchem Group AG's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alzchem Group AG Cash Conversion Cycle vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Alzchem Group AG's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Alzchem Group AG's Cash Conversion Cycle falls into.
Alzchem Group AG Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Alzchem Group AG's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alzchem Group AG (XTER:ACT) has a Cash Conversion Cycle of 174.81 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Alzchem Group AG and its competitors.
Is Alzchem Group AG's Cash Conversion Cycle too high?
Alzchem Group AG's current Cash Conversion Cycle is 174.81. The Chemicals industry median Cash Conversion Cycle is 89.14. Alzchem Group AG's value of 174.81 is 96.1% above this industry median. Overall, Alzchem Group AG has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Cash Conversion Cycle compare to LIN and SHW?
Alzchem Group AG's Cash Conversion Cycle of 174.81 can be compared against companies in the Chemicals industry. The industry median Cash Conversion Cycle is 89.14. Alzchem Group AG's value of 174.81 is 96.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Chemicals company?
The median Cash Conversion Cycle among Chemicals companies is 89.14, based on 1,586 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alzchem Group AG's current Cash Conversion Cycle of 174.81 is 96.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Alzchem Group AG and its competitors. For the Chemicals industry, the median Cash Conversion Cycle is 89.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alzchem Group AG's current Cash Conversion Cycle is 174.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (XTER:ACT) has a current Cash Conversion Cycle of 174.81. The current Cash Conversion Cycle is 174.81 and 96.1% above the Chemicals industry median of 89.14. Alzchem Group AG's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Alzchem Group AG (XTER:ACT), the current Cash Conversion Cycle is 174.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
56GF Score
Get the complete analysis for XTER:ACT
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:ACT has been successfully added to your 
